We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ADVERTISEMENT
Africanian
  • News
  • News 24/7
  • Politics
  • Business
  • Health
  • Sports
  • Travel
  • World
    • US
    • Russia
    • Europe
    • Asia
    • America
  • Events
No Result
View All Result
Africanian
No Result
View All Result
Home World

Introducing ‘Vaxzevria’: AstraZeneca renames Covid vaccine as firm fights off controversy over drug

AstraZeneca has renamed its Covid-19 vaccine, a move that coincides with the company’s struggle to reassure the public that its drug is safe, following numerous reports of potential adverse effects.

in World
Reading Time: 2 mins read
1 0
0
Introducing ‘Vaxzevria’: AstraZeneca renames Covid vaccine as firm fights off controversy over drug
5
SHARES
Share on FacebookShare on TwitterShare via Whatsapp

More

India leads a technical response following the Boeing 787 crash

China implements visa exemption for Saudi Arabia, Oman, Kuwait, and Bahrain

Is the United States of America Still the Land of Opportunity?

The British-Swedish pharmaceutical has rebranded its jab, which previously went by the simple ‘AstraZeneca Covid-19 Vaccine’, to ‘Vaxzevria’. In a press release, the company said that the name change does not involve any alterations to the actual drug. Medical workers should be made aware of the rebrand though, the firm said, because the labeling and packaging can look different.

The European Medicines Agency signed off on the new name last week after AstraZeneca sought approval for the change from the EU regulator. Covishield, which is based on the same formula but was developed in collaboration with the Serum Institute of India, will retain its current branding.

The debut of ‘Vaxzevria’ comes as AstraZeneca fends off growing uncertainty about its drug, which was created in tandem with Oxford University. More than a dozen countries across Europe have temporarily halted their rollout of the vaccine following reports of blood clots. EU health officials, as well as the pharma firm, have maintained that the vaccine is safe and not related to the medical episodes, some of which led to death.

On Monday, Canada joined the growing list of countries that have suspended or placed restrictions on the drug’s use. Citing potential safety concerns, the country said that the vaccine would not be administered to people younger than 55.

The company was hit with more bad press after US regulators raised concerns that trial data used to gauge the efficacy of the vaccine was potentially outdated and misleading. AstraZeneca said that it was working to update and verify the trial’s findings. The vaccine has not yet been approved for emergency use in the United States.

Despite reassurances from the medical bodies and governments, Europeans appear to be growing increasingly distrustful of the AstraZeneca drug. A poll released by YouGov last Monday revealed that only 23% of French people and 32% of Germans consider the vaccine to be safe.

However, it’s not clear whether the ‘Vaxzevria’ name change was motivated by the bad publicity, as the trademark application for the drug dates back to December.

Source: rt.com
africanian

africanian

  • Trending
  • Comments
  • Latest
Rwanda combines youth innovation and circular economy to build a resilient nation

Rwanda combines youth innovation and circular economy to build a resilient nation

July 3, 2025
Weather in South Africa: Climate and Seasons

Weather in South Africa: Climate and Seasons

August 25, 2020
Weather in Kenya: Climate, Seasons, and Average Temperature

Weather in Kenya: Climate, Seasons and Average Temperature

August 26, 2020
In Tanzania, the Kibuka community has improved their household economy by more than 50%.

In Tanzania, the Kibuka community has improved their household economy by more than 50%.

July 11, 2025
Lesotho increases blood collection by 70% between 2017 and 2024

Lesotho increases blood collection by 70% between 2017 and 2024

July 8, 2025
Nigeria accelerates economic transformation with key reforms and signs of recovery

Nigeria accelerates economic transformation with key reforms and signs of recovery

July 7, 2025
Twitter Instagram Youtube Facebook
No Result
View All Result

Africanian News

Is a dedicated project aimed at amplifying the voices of the African Ecosystem and Diaspora. We actively collaborate with initiatives to improve access to education and digital inclusion, both in traditional schools and through digital platforms, for African children.

It’s crucial to emphasize that none of the articles or images featured on our platform are intended for copyright infringement, neither now nor in the future. If you believe that any information, text, image, etc., may be subject to copyright and should be removed, please notify us by sending an email to info@africanian.com

Your dreams matter; your stories matter.

Feel free to explore collaboration opportunities with us. Share your articles, thoughts, interviews, experiments, or no-comment videos by reaching out to info@africanian.com. You can also subscribe to our mailing list to receive the latest updates from Africanian News.

© 2024 Africanian News: From Africa, by Africans, for Africa, and friends of Africa.

No Result
View All Result
  • News
  • Politics
  • Business
  • Health
  • Sports
  • Entertainment
  • Tech
  • Travel
  • World

© 2024 Africanian News: From Africa, by Africans, for Africa, and friends of Africa.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Log In

Sign In

Forgot password?

Don't have an account? Register

Forgot password?

Enter your account data and we will send you a link to reset your password.

Back to Login

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Accept

Add to Collection

  • Public collection title

  • Private collection title

No Collections

Here you'll find all collections you've created before.